Your browser doesn't support javascript.
loading
Treatment effectiveness for Vocal Cord Dysfunction in adults and adolescents: A systematic review.
Mahoney, Janine; Hew, Mark; Vertigan, Anne; Oates, Jennifer.
Afiliación
  • Mahoney J; Speech Pathology, LaTrobe University, Melbourne, Victoria, Australia.
  • Hew M; Speech Pathology Department, The Alfred, Melbourne, Victoria, Australia.
  • Vertigan A; Allergy, Asthma and Clinical Immunology Service, The Alfred, Melbourne, Victoria, Australia.
  • Oates J; Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
Clin Exp Allergy ; 52(3): 387-404, 2022 03.
Article en En | MEDLINE | ID: mdl-34699093
ABSTRACT

OBJECTIVE:

To determine whether treatment effectiveness can be established for a range of vocal cord dysfunction (VCD) interventions in adolescents and adults.

DESIGN:

A systematic review of the literature and risk of bias appraisal was completed using the Joanna Briggs Institute Critical Appraisal Tools. Data were qualitatively synthesized in the broad intervention groups of glottic airway and respiratory retraining, pharmacological therapies, airway device therapies and psychological therapies. DATA SOURCES Nine electronic databases, two clinical trial registries and the grey literature were searched from inception to September 2021 for articles on VCD interventions or equivalent terms. ELIGIBILITY CRITERIA Studies were included if they were randomized controlled trials, non-randomized controlled trials, quasi-experimental pre- and post-test studies and within-subject repeated measure designs, participants were 13 years or older, VCD was diagnosed using laryngoscopy or CT larynx, VCD intervention was provided and outcome measures reported on VCD symptoms.

RESULTS:

The search yielded no randomized controlled trials. There were 17 quasi-experimental studies that met the eligibility criteria, and these studies reported on glottic airway and respiratory retraining, botulinum toxin injections, inspiratory muscle strength training and amitriptyline; all were associated with VCD symptom reduction. In addition, 2 within-subject repeated measure studies reported inspiratory muscle strength training and respiratory retraining to be effective in reducing symptoms in participants with exertional VCD. The included studies were reported in full-text publications (11) and conference proceedings (8). There was a high risk of bias and low quality of evidence across all intervention areas.

CONCLUSION:

Glottic airway and respiratory retraining, botulinum toxin injections, low-dose amitriptyline and inspiratory muscle strength training devices have been associated with symptom reduction in adults and adolescents with vocal cord dysfunction. Limited objective data exist to support the effectiveness of these interventions, and robust controlled trials are needed in this area. Systematic Review Registration CRD42018092274 (PROSPERO).
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Disfunción de los Pliegues Vocales Tipo de estudio: Clinical_trials / Diagnostic_studies / Systematic_reviews Límite: Adolescent / Adult / Humans Idioma: En Revista: Clin Exp Allergy Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Australia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Disfunción de los Pliegues Vocales Tipo de estudio: Clinical_trials / Diagnostic_studies / Systematic_reviews Límite: Adolescent / Adult / Humans Idioma: En Revista: Clin Exp Allergy Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Australia